Literature DB >> 2705376

Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.

M A Brodsky1, B J Allen, E V Capparelli, C R Luckett, R Morton, W L Henry.   

Abstract

Successful therapy of atrial fibrillation (AF) has been reportedly influenced by a variety of factors including patient age, type of underlying heart disease, duration of arrhythmia, left ventricular function and left atrial (LA) size. To determine which of these factors are associated with maintenance of sinus rhythm after conversion, 43 patients with symptomatic chronic AF in the setting of a dilated left atrium (greater than or equal to 45 mm, range 45 to 78) were followed for at least 6 months after the return of sinus rhythm. Class IA drugs, IC drugs or amiodarone were used for therapy. Life table analysis showed sinus rhythm to be maintained in 81% for 6 months, 79% for 12 months and 60% for 24 months. Factors positively associated with success were conversion with drug therapy alone, duration of chronic AF less than or equal to 1 year, absence of mitral valve disease and LA dimension less than or equal to 60 mm (all p less than 0.05). Patient age, left ventricular function and presence of coronary disease were not associated with outcome. Thus, patients with moderate LA dilatation (45 to 60 mm) and a short duration of chronic AF can often be maintained in sinus rhythm, especially if they convert with pharmacologic intervention alone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705376     DOI: 10.1016/0002-9149(89)90079-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  33 in total

1.  Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.

Authors:  A R Houghton; A Sharman; J E Pohl
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

Review 2.  Physiology and pathophysiology of the atria: its role in atrial fibrillation.

Authors:  J Godtfredsen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

3.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

Review 4.  The role of coumadin and aspirin in atrial fibrillation.

Authors:  A M Hutter
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

5.  Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks.

Authors:  S M Sopher; F D Murgatroyd; A K Slade; I Blankoff; E Rowland; D E Ward; A J Camm
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

6.  Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation.

Authors:  Koichi Sakabe; Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

7.  AF Detected on Implanted Cardiac Implantable Electronic Devices: Is There a Threshold for Thromboembolic Risk?

Authors:  Motaz Baibars; Khalil Kanjwal; Joseph E Marine
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

8.  Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal-averaged ECG.

Authors:  Marco Budeus; Marcus Hennersdorf; Christian Perings; Heinrich Wieneke; Raimund Erbel; Stefan Sack
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

9.  Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?

Authors:  Dariusz A Kosior; Marcin Szulc; Grzegorz Opolski; Adam Torbicki; Daniel Rabczenko
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

10.  Haemostatic activity in patients with atrial fibrillation treated with low-molecular-weight heparin before and after electrical cardioversion.

Authors:  Elisabeth L Zeuthen; Jens Flensted Lassen; Steen E Husted
Journal:  J Thromb Thrombolysis       Date:  2004-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.